Advancing Signal Detection with GenAI

Industry Panel Webinar: How GenAI is Changing Regulatory Affairs

Hans van Leeuwen
Global Head of Regulatory Operations – Astellas

Steve Gens
Managing Partner – Gens & Associates

Michael Sonntag
Director, Global Regulatory Affairs & PV – Wörwag Pharma

See where AI and automation drive the greatest time and cost savings.

Webinar

Advancing Signal Detection with GenAI

GenAI-powered advancements enable safety teams to achieve remarkable efficiency and precision gains, alongside optimized patient safety and business outcomes.

Seamlessly integrate technologies available now and layer advanced signaling automation and analytics into existing PV safety systems in months and deliver practical, real-world results with ease.

Join us for an exclusive webinar highlighting the latest groundbreaking technologies in signal detection and evaluation.

"*" indicates required fields

First Name*

Last Name*

Email*

Job Title*

Company Name*

HQ Country*

Demo signup

Name

This field is for validation purposes and should be left unchanged.

Please view our Privacy Policy for information on how ArisGlobal handles customer data.

Moderator

Garrett Hess
Senior Director, Product Marketing – ArisGlobal

Speakers

Paramdeep Singh Gill
Associate Vice President, PM – ArisGlobal

Amritdeep Gill
Global Head of Consumer Safety, GMPV – Opella

LifeSphere® Technology is trusted by these industry leaders:

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Quick Links

Follow Us

Font resize

Contrast

Accessibility by WAH